In vitro activity of Ro 23-9424 against clinical isolates of Legionella species.
AUTOR(ES)
Edelstein, P H
RESUMO
Agar and broth microdilution MICs of Ro 23-9424 that inhibited 90% of 22 Legionella clinical isolates tested were 0.64 and 0.08 micrograms/ml, respectively; respective erythromycin values were 1.0 and 0.12 micrograms/ml. Ro 23-9424 (1 microgram/ml) was slightly more active than the same erythromycin concentration in a macrophage system, for both Legionella pneumophila strains studied.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=284376Documentos Relacionados
- Low-level resistance to the cephalosporin 3'-quinolone ester Ro 23-9424 in Escherichia coli.
- In vitro activity of azithromycin against clinical isolates of Legionella species.
- In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents.
- In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics.
- Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals.
